HOME    | Hepatitis B     | Hepatitis C  
<--- Return to the 56th AASLD Main Page
HIVandHepatitis.com Coverage of Highlights from the
56th Annual Meeting of the American
Association for the Study of Liver Diseases
 November 11 - 15, 2005 San Francisco, California


Adverse Events / Fatigue / Psychiatric Disorders

Treatment of Genotype 1 Chronic Hepatitis C: Increased Sustained Virological Response with High-dose RBV and Epoetin - 11/23/05

Fatigue Adversely Affects Virologic Response to Peginterferon Plus Ribavirin - 11/21/05

Does Psychiatric lllness Affect Compliance, Ability to Complete Treatment or the Response to Treatment with Peginterferon Plus Ribavirin? - 11/21/05

Final Results of a Phase 1B, Multiple-dose Study of VX-950, a Hepatitis C Virus Protease Inhibitor - 11/14/05

 



<--- Return to the 56th AASLD Main Page